Celltrion posts record Q2 sales as profitability improves

Celltrion said Friday it posted record second-quarter sales and a 77.3 percent jump in operating profit, as newer, higher-margin products helped lift margins and push earnings above its own guidance.

The Korean biopharmaceutical company reported preliminary consolidated revenue of 1.3 trillion won ($845 million) and operating profit of 430 billion won for the April-June period.

Revenue rose 35.2 percent from a year earlier, marking Celltrion’s highest-ever second-quarter sales, while operating p ...